欧莱雅的进击

Core Viewpoint - L'Oréal is actively expanding its market presence through acquisitions and investments, particularly in the medical aesthetics sector, in response to slowing growth in its core business [1][9]. Group 1: Acquisition and Investment Strategy - L'Oréal has acquired an additional 10% stake in Galderma, increasing its ownership to 20%, following an initial investment in 2024 [2]. - The acquisition aligns with L'Oréal's strategy to enhance its presence in the medical aesthetics market, which includes products like injectables and skincare treatments [2][3]. - L'Oréal's CEO emphasized the importance of the aesthetics business as a key extension of its core beauty operations, indicating a strong commitment to this market [2]. Group 2: Market Context and Performance - L'Oréal's sales for the first three quarters of the year reached €32.8 billion, reflecting a growth rate of approximately 1.2%, a significant decline from the previous year's 6% [9]. - The company reported a sales decline of 1.1% in the North Asia market for the first half of 2025, highlighting challenges in this key region [9]. - Overall, L'Oréal's growth has slowed, with a projected annual sales increase of only 5.1% for 2024, compared to much higher growth rates in previous years [9]. Group 3: Broader Market Trends - L'Oréal is not only focusing on the medical aesthetics sector but is also building a comprehensive beauty ecosystem that includes luxury, mass-market, skincare, and haircare products [5]. - The company has established a long-term strategic partnership with Kering Group, involving a €4 billion acquisition of several luxury beauty brands [6]. - Recent investments in domestic beauty brands, such as a stake in Naturals and LAN, indicate L'Oréal's strategy to tap into the growing potential of the Chinese beauty market [6].